ArticleClinical and translational radiation oncology2025
Comment on "PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer".
Parth Aphale et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.